The annual fee that you pay to the fund company for managing your investment. The lower the expense ratio, the better. This is not an investment recommendation.

Dividends

1.2%Dividend Yield

Dec 25

$0.91

Sep 25

$0.1

Jul 25

$0.22

Apr 25

$0.11

Jul 24

$0.15

10Y Growth

N/A

5Y Growth

N/A

3Y Growth

42.71%

1Y Growth

-8%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow LABU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Direxion Daily S&P Biotech Bear 3X

LABD

Mkt Cap0

Direxion Daily S&P Biotech Bear 3X Shares, the inverse ETF of LABU, offering 3X leveraged exposure in the opposite direction.

ProShares Ultra Nasdaq Biotechnology 2X Shares

BIB

Mkt Cap0

ProShares Ultra Nasdaq Biotechnology, a 2X leveraged ETF focusing on the biotech sector, similar to LABU but with less leverage.

ProShares UltraShort Nasdaq Biotechnology -2x Shares

BIS

Mkt Cap0

ProShares UltraShort Nasdaq Biotechnology, offers 2X leveraged inverse exposure to the biotech sector, competing with LABU's bear counterpart.

State Street SPDR S&P Biotech

XBI

Mkt Cap0

SPDR S&P Biotech ETF, a non-leveraged ETF that tracks the biotech sector, competing for the same investor base as LABU.

iShares Biotechnology

IBB

Mkt Cap0

iShares Nasdaq Biotechnology ETF, another major non-leveraged biotech ETF, competing in the biotech investment space with LABU.

VanEck Biotech

BBH

Mkt Cap0

VanEck Vectors Biotech ETF, offers exposure to the biotech industry, competing with LABU for biotech-focused investments.

First Trust NYSE Arca Biotechnology Index Fund

FBT

Mkt Cap0

First Trust NYSE Arca Biotechnology Index Fund, a non-leveraged ETF competing in the biotech sector investment space.

ALPS Medical Breakthroughs

SBIO

Mkt Cap0

ALPS Medical Breakthroughs ETF, focuses on smaller companies in the biotech sector, offering a different approach but still competing for biotech investors.

ARK Genomic Revolution

ARKG

Mkt Cap0

ARK Genomic Revolution ETF, focuses on genomics and biotech, competing with LABU by targeting innovation in the biotech space.

Invesco Biotechnology & Genome

PBE

Mkt Cap0

Invesco Dynamic Biotechnology & Genome ETF, offers exposure to the biotech and genomic sector, competing for similar investment interests.

Holdings

Regions

Sectors

About

The Direxion Daily S&P Biotech Bull and Bear 3X ETFs seek daily investment results, before fees and expenses, of 300%, or 300% of the inverse (or opposite), of the performance of the S&P Biotechnology Select Industry Index. There is no guarantee the funds will achieve their stated investment objectives.

CEO

Country

United States

ISIN

US25460G1206

Listings

0 Comments

Share your thoughts

FAQ

What is Direxion Daily S&P Biotech Bull 3X stock price today?▼

The current price of LABU is $187.14 USD — it has increased by +0.56% in the past 24 hours. Watch Direxion Daily S&P Biotech Bull 3X stock price performance more closely on the chart.

What is Direxion Daily S&P Biotech Bull 3X stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange Direxion Daily S&P Biotech Bull 3X stocks are traded under the ticker LABU.

Is Direxion Daily S&P Biotech Bull 3X stock price growing?▼

LABU stock has risen by +11.19% compared to the previous week, the month change is a +9.79% rise, over the last year Direxion Daily S&P Biotech Bull 3X has showed a +290.44% increase.

Does Direxion Daily S&P Biotech Bull 3X pay dividends?▼

Yes, LABU dividends are paid quarterly. The last dividend per share was 0.91 USD. As of today, Dividend Yield (FWD)% is 1.2%.

In which sector is Direxion Daily S&P Biotech Bull 3X located?▼

Direxion Daily S&P Biotech Bull 3X operates in the Other sector.

When did Direxion Daily S&P Biotech Bull 3X complete a stock split?▼

The last stock split for Direxion Daily S&P Biotech Bull 3X was on December 04, 2023 with a ratio of 1:20.